Latest News and Press Releases
Want to stay updated on the latest news?
-
HighlightsIndependent third-party testing and analysis concludes Sientra implants continue to be safe choice for surgeons and patientsSales of FDA-approved product portfolio has been initiated as of...
-
SANTA BARBARA, Calif., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that the Company will release its fourth quarter and full year...
-
SANTA BARBARA, Calif., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced all of its medical devices, including...
-
Promotes Charles Huiner to Chief Operating Officer and Senior Vice President of Corporate Development & Strategy Promotes Chief Financial Officer Matthew Pigeon to Chief Financial Officer and...
-
Highlights Third quarter total sales of $9.9 million, which includes an additional $3.0 million allowance for product returns Total sales for the first nine months of 2015 of $36.6 million,...
-
SANTA BARBARA, Calif., Nov. 12, 2015 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) ("Sientra" or "the Company"), a medical aesthetics company, announced that Jeffrey Nugent has been appointed...
-
SANTA BARBARA, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today provided an update regarding its business, including additional details...
-
SANTA BARBARA, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that the Company will host an investor and analyst update conference...
-
SANTA BARBARA, Calif., Oct. 23, 2015 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today issued the following statement regarding a recent development at Silimed's...
-
SANTA BARBARA, Calif., Oct. 9, 2015 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, today announced that it has sent a letter to plastic surgeons regarding products...